HomeAM6 • FRA
add
Amicus Therapeutics, Inc.
Nakaraang pagsara
€7.95
Sakop ng araw
€7.95 - €7.95
Sakop ng taon
€7.85 - €11.10
Market cap
2.65B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 149.71M | 30.09% |
Gastos sa pagpapatakbo | 118.90M | 10.66% |
Net na kita | 14.74M | 143.55% |
Net profit margin | 9.85 | 133.49% |
Kita sa bawat share | 0.09 | 800.00% |
EBITDA | 18.01M | 1,292.85% |
Aktuwal na % ng binabayarang buwis | -85.77% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 249.95M | -12.67% |
Kabuuang asset | 785.03M | 0.92% |
Kabuuang sagutin | 590.99M | -4.33% |
Kabuuang equity | 194.04M | — |
Natitirang share | 300.12M | — |
Presyo para makapag-book | 12.23 | — |
Return on assets | 5.08% | — |
Return on capital | 6.33% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 14.74M | 143.55% |
Cash mula sa mga operasyon | -3.92M | -213.24% |
Cash mula sa pag-invest | -20.39M | 14.88% |
Cash mula sa financing | 1.10M | -86.64% |
Net change in cash | -20.10M | -24.14% |
Malayang cash flow | 8.65M | 215.80% |
Tungkol
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Itinatag
Peb 4, 2002
Website
Mga Empleyado
499
